<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">PBES</journal-id><journal-title-group><journal-title>Proceedings of Business and Economic Studies</journal-title></journal-title-group><issn>2209-2641</issn><eissn>2209-265X</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/pbes.v3i6.1710</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Research on the Solvency of Tibetan Pharmaceutical Companies in the New Era</title><url>https://artdesignp.com/journal/PBES/3/6/10.26689/pbes.v3i6.1710</url><author>WangYanan</author><pub-date pub-type="publication-year"><year>2021</year></pub-date><volume>3</volume><issue>6</issue><history><date date-type="pub"><published-time>2021-01-13</published-time></date></history><abstract>Medical care is a livelihood needs, and the solvency directly affects the survival and development of pharmaceutical companies. Therefore, it is important to study the solvency of pharmaceutical companies. This article selects six listed Tibetan pharmaceutical companies as research cases, adopts a comparative analysis method to analyze their solvency, and explores the advantages and disadvantages of the solvency of Tibetan pharmaceutical companies in order to enhance the solvency of Tibetan pharmaceutical companies for reference.</abstract><keywords/></article-meta></front><body/><back><ref-list/></back></article>
